Results 61 to 70 of about 9,895 (133)

Rapid Native and Bioprosthetic Tricuspid Valve Degeneration in Carcinoid Heart Disease

open access: yesJACC: Case Reports
Background: Carcinoid heart disease (CaHD) is a severe complication of metastatic neuroendocrine tumors characterized by serotonin-mediated fibrotic degeneration of right-sided cardiac valves.
Lucia Trabucchi, MS   +9 more
doaj   +1 more source

Transjugular tricuspid valve‐in‐ring replacement using the novel system under three‐dimensional printing guidance

open access: yesESC Heart Failure
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj   +1 more source

Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late

open access: yesStructural Heart
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD   +6 more
doaj   +1 more source

Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures

open access: yesLife
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos   +8 more
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives

open access: yesReviews in Cardiovascular Medicine
Tricuspid regurgitation (TR) is a potentially lethal condition and represents a significant clinical challenge both for clinical and interventional cardiologists. Traditionally managed medically and surgically, transcatheter therapies are now an emerging
Guido Del Monaco   +5 more
doaj   +1 more source

Transcatheter aortic valve replacement for severe aortic regurgitation in quadricuspid aortic valve: a case report

open access: yesFrontiers in Cardiovascular Medicine
A 49-year-old woman with a congenital quadricuspid aortic valve presented in cardiogenic shock due to severe aortic regurgitation. She underwent transfemoral transcatheter aortic valve replacement with a 29 mm self-expanding prosthesis. The procedure was
Abdullah Aljudaibi   +2 more
doaj   +1 more source

Mid-Term Outcomes and Echocardiographic Predictors of TTVR: Insights from the TRAVEL Study

open access: yesJournal of Cardiovascular Development and Disease
Background: The mid-term prognosis after transcatheter tricuspid valve replacement (TTVR) is poorly defined, and echocardiographic predictors remain uncertain.
Xing Zhao   +8 more
doaj   +1 more source

Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement

open access: yesStructural Heart
The recent development and approval of a transcatheter tricuspid valve represent a significant breakthrough in the management of patients with tricuspid regurgitation who are not suitable for existing invasive or interventional therapies.
Andreas Hain, MD   +6 more
doaj   +1 more source

Early Prosthetic Thrombosis After Transcatheter Tricuspid Valve Replacement: A Word of Caution. [PDF]

open access: yesJACC Case Rep
Trinca F   +9 more
europepmc   +1 more source

Transcatheter tricuspid valve replacement-a comparison of clinical and procedural outcomes of two different prostheses. [PDF]

open access: yesFront Cardiovasc Med
Genske F   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy